Bloomberg Law
Free Newsletter Sign Up
Bloomberg Law
Free Newsletter Sign Up

Brazil Agency Suspends Import License for Covaxin Vaccine

July 27, 2021, 1:58 PM

Board of directors of Brazil’s health agency unanimously decided to suspend the temporary authorization for importing and distribution of the Covaxin vaccine, requested by the country’s Health Ministry, according to a statement from the agency.

  • Dercision will last until new information is provided to confirm the legal and technical aspects of the authorization
  • Decision was taken after Bharat Biotech Limited International, which makes the vaccine, informed that Precisa Medicamentos is no longer authorized to represent the company in Brazil

To see the source of this information, click here

Original Story:
Anvisa suspende autorização de importação da vacina Covaxin

To contact ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.